| Literature DB >> 25960877 |
Dong Zhao1, Jianxin Zhou2, Go Haraguchi3, Hirokuni Arai4, Chieko Mitaka3.
Abstract
BACKGROUND: This study was performed to assess the value of procalcitonin (PCT) for the differential diagnosis between infectious and non-infectious systemic inflammatory response syndrome (SIRS) after cardiac surgery.Entities:
Keywords: C-reactive protein; Cardiac surgery; Infection; Procalcitonin; Systemic inflammatory response syndrome
Year: 2014 PMID: 25960877 PMCID: PMC4424708 DOI: 10.1186/2052-0492-2-35
Source DB: PubMed Journal: J Intensive Care ISSN: 2052-0492
The comparison between the infectious and non-infectious groups
| Infectious SIRS ( | Non-infectious SIRS ( |
| |
|---|---|---|---|
| Age (year) | 67.8 ± 15.7 | 67.2 ± 13.3 | 0.81 |
| Gender, | 0.77 | ||
| Male | 32 (68.1) | 67 (70.5) | |
| Female | 15 (31.9) | 28 (29.5) | |
| Type of surgery, | |||
| Valve surgery | 16 (34.0) | 36 (37.9) | 0.65 |
| CABG | 9 (19.1) | 11 (11.6) | 0.22 |
| Vessel replacement | 13 (27.7) | 21 (22.7) | 0.47 |
| VAD | 3 (6.4) | 1 (1.1) | 0.11 |
| Interventional therapy | 1 (2.1) | 14 (14.7) | 0.02 |
| Complex surgery | 5 (10.6) | 12 (12.6) | 0.73 |
| BMI, kg/m2 | 21.8 (20.0,26.7) | 22.7 (20.4,24.7) | 0.64 |
| Concomitant disease, | |||
| Diabetes mellitus | 18 (38.3) | 25 (26.3) | 0.14 |
| Hypertension | 20 (42.6) | 35 (36.8) | 0.51 |
| CKD | 19 (40.4) | 21 (22.1) | 0.02 |
| CPB duration, min | 197.2 ± 142.5 | 173.6 ± 123.5 | 0.31 |
| Aortic cross clamping, min | 99.0 ± 100.1 | 98.3 ± 84.7 | 0.96 |
| Operation time, min | 508.9 ± 192.4 | 466.3 ± 174.9 | 0.19 |
| Blood loss, mL | 3,512 ± 3,150 | 3,189 ± 2,706 | 0.53 |
| APACHE II | 19.0 (15.0,25.0) | 11.0 (9.0,14.0) | 0.001 |
| SOFA | 7.0 ± 2.6 | 5.1 ± 2.1 | 0.001 |
| PCT, ng/mL | 2.80 (1.24,10.20) | 0.10 (0.06,0.21) | 0.001 |
| WBC, ×103/μL | 15.5 (11.0,22.6) | 9.3 (7.2,12.6) | 0.001 |
| CRP, mg/dL | 15.8 (12.0,19.9) | 5.8 (2.5,8.9) | 0.001 |
| ICU stay, day | 23.0 (12.0,52.0) | 5.0 (3.0,6.0) | 0.001 |
| Hospital stay, day | 82.0 (37.0,149.0) | 31.0 (23.0,45.0) | 0.001 |
| MV duration, h | 264.0 (40.0,999.0) | 17.0 (10.0,39.0) | 0.001 |
| CRRT, | 26 (55.3) | 5 (5.3) | 0.001 |
| PMX-DHP, | 18 (38.3) | 0 | 0.001 |
| ECMO, | 13 (27.7) | 0 | 0.001 |
| DIC, | 23 (48.9) | 0 | 0.001 |
| 30-Day mortality, | 3 (6.38) | 0 | 0.035 |
| Hospital mortality, | 22 (46.8) | 0 | 0.001 |
CABG coronary artery bypass graft, VAD ventricular assist device, BMI body mass index, CKD chronic kidney disease, CPB cardiopulmonary bypass, APACHE II acute physiology and chronic health evaluation II, SOFA sequential organ failure assessment, MV mechanical ventilation, CRRT continuous renal replacement therapy, PMX-DHP polymyxin B-immobilized fiber column direct hemoperfusion, ECMO extracorporeal membrane oxygenation, DIC disseminated intravascular coagulation.
Figure 1The ROC curves of PCT, CRP, and WBC for predicting infection.
The comparison of infectious subgroups
| Sepsis ( | Severe sepsis without shock ( | Septic shock ( |
| |
|---|---|---|---|---|
| Age (year) | 70.6 ± 13.7 | 65.2 ± 19.0 | 67.8 ± 15.3 | 0.716 |
| Gender, | 0.058 | |||
| Male | 5 (45.5) | 11 (91.7) | 16 (66.7) | |
| Female | 6 (54.5) | 1 (8.3) | 8 (33.3) | |
| BMI, kg/m2 | 21.6 (18.4,24.1) | 20.6 (20.1,21.7) | 23.9 (20.5,28.8) | 0.090 |
| Concomitant disease, | ||||
| Diabetes mellitus | 3 (27.3) | 6 (50.0) | 9 (37.5) | 0.531 |
| Hypertension | 5 (45.5) | 3 (25.0) | 12 (50.0) | 0.351 |
| CKD | 4 (36.4) | 2 (16.7) | 13 (54.2) | 0.001 |
| CPB duration, min | 102.0 ± 129.4 | 187.5 ± 134.8 | 245.6 ± 133.4 | 0.017 |
| Aortic cross clamping, min | 69.4 ± 92.4 | 108.8 ± 84.2 | 107.8 ± 111.4 | 0.542 |
| Operation time, min | 418.5 ± 136.1 | 540.8 ± 121.7 | 534.5 ± 231.9 | 0.206 |
| Blood loss, mL | 802 (398,2489) | 6790 (1364,8324) | 2530 (1227,4961) | 0.019 |
| APACHE II | 15.5 ± 6.1 | 16.8 ± 7.6 | 23.5 ± 6.2 | 0.002 |
| SOFA | 5.5 ± 1.4 | 5.9 ± 2.9 | 8.2 ± 2.5 | 0.004 |
| ICU stay, day | 12.0 (4.0,23.0) | 13.0 (7.3,24.5) | 49.5 (17.8,81) | 0.001 |
| Hospital stay, day | 60.9 ± 59.6 | 114.2 ± 85.5 | 124.5 ± 101.0 | 0.152 |
| 30-Day mortality, | 0 | 0 | 3 (12.5) | 0.215 |
| Hospital mortality, | 0 | 0 | 22 (91.7) | 0.001 |
| MV duration, h | 40.0 (16.0,183.0) | 58.5 (13.5,404.3) | 992.5 (276.3,1559.3) | 0.001 |
| CRRT, | 3 (27.3) | 2 (16.7) | 21 (87.5) | 0.001 |
| PMX-DHP, | 0 | 0 | 17 (70.8) | 0.001 |
| ECMO, | 0 | 1 (8.3) | 12 (50.0) | 0.001 |
| DIC, | 0 | 1 (8.3) | 22 (91.7) | 0.024 |
| PCT, ng/mL | 1.37 (0.72,1.85) | 3.16 (0.48,13.24) | 3.68 (1.67,20.96) | 0.024 |
| WBC, ×103/μL | 12.40 (9.10,24.20) | 13.30 (9.93,16.93) | 20.40 (13.45,28.6) | 0.060 |
| CRP, mg/dL | 12.00 (7.40,18.00) | 13.57 (8.17,18.13) | 17.11 (15.15,30.6) | 0.009 |
| Gram positive, | ||||
| MRSA | 0 | 0 | 6 (25.0) | 0.037 |
| | 2 (18.7) | 4 (33.3) | 1 (4.2) | 0.064 |
| | 0 | 0 | 3 (12.5) | 0.215 |
| | 0 | 0 | 3 (12.5) | 0.215 |
| Gram negative, | ||||
| | 0 | 2 (16.7) | 2 (8.3) | 0.359 |
| | 1 (9.1) | 1 (8.3) | 3 (12.5) | 0.913 |
| | 1 (9.1) | 1 (8.3) | 1 (4.2) | 0.815 |
| | 1 (9.1) | 1 (8.3) | 0 | 0.335 |
|
| ||||
| | 4 (36.4) | 2 (16.7) | 3 (12.5) | 0.242 |
| | 0 | 0 | 2 (8.3) | 0.368 |
| | 0 | 1 (8.3) | 1 (4.2) | 0.613 |
| | 1 (9.1) | 1 (8.3) | 1 (4.2) | 0.815 |
MRSA methicillin-resistant Staphylococcus aureus; for other abbreviations, see Table 1.
Figure 2ROC curves of PCT and CRP for predicting (A) severe sepsis without shock and (B) septic shock.